Yahoo Finance

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 13, 2016) - Response Biomedical Corp. ("Response" or the "Company") (RBM.TO)(RPBIF), in accordance with the requirements of the Toronto Stock Exchange, is pleased to announce the results of voting at its 2016 Annual General and Special Meeting of Shareholders held earlier today.

A total of 6,110,535 common shares were represented at the meeting, representing approximately 62% of the issued and outstanding common shares of the Company. Shareholders voted as follows:

1. Election of Directors

By resolution passed by show of hands, the number of Directors of the Company was set at seven. By resolution passed by ballot vote, the following seven nominees proposed by Management were elected as Directors of the Company to hold office until the next Annual Meeting of Shareholders or until their successors are elected or appointed:

1. Appointment of Auditor

By resolution passed by show of hands, PricewaterhouseCoopers LLP, Chartered Professional Accountants, was appointed auditor of the Company for the ensuing year.

1. Approval of Unallocated Options, Rights, and Other Entitlements Under the Amended Option Plan
   

By resolution passed by ballot vote, the approval of all unallocated options, rights, and other entitlements and the ability of the Company to continue granting options under its Amended and Restated 2008 Stock Option Plan until June 13, 2019, were approved. The results of the ballot were as follows:

5,049,343 shares held by insiders of the Company were not counted for purposes of this resolution.

1. Approval of Unallocated Entitlements Under the Restricted Share Unit Plan ("RSU Plan")

By resolution passed by ballot vote, the approval of all unallocated entitlements and the ability of the Company to continue granting Restricted Share Units under its RSU Plan until June 13, 2019, were approved. The results of the ballot were as follows:

5,049,343 shares held by insiders of the Company were not counted for purposes of this resolution.